Abstract
Propensity for subsequent distant metastasis in head and neck squamous-cell carcinoma (HNSCC) was analysed using 186 primary tumours from patients initially treated by surgery that developed (M) or did not develop (NM) metastases as the first recurrent event. Transcriptome (Affymetrix HGU133_Plus2, QRT–PCR) and array-comparative genomic hybridization data were collected. Non-supervised hierarchical clustering based on Affymetrix data distinguished tumours differing in pathological differentiation, and identified associated functional changes. Propensity for metastasis was not associated with these subgroups. Using QRT–PCR data we identified a four-gene model (PSMD10, HSD17B12, FLOT2 and KRT17) that predicts M/NM status with 77% success in a separate 79-sample validation group of HNSCC samples. This prediction is independent of clinical criteria (age, lymph node status, stage, differentiation and localization). The most significantly altered transcripts in M versus NM were significantly associated to metastasis-related functions, including adhesion, mobility and cell survival. Several genomic modifications were significantly associated with M/NM status (most notably gains at 4q11–22 and Xq12–28; losses at 11q14–24 and 17q11 losses) and partly linked to transcription modifications. This work yields a basis for the development of prognostic molecular signatures, markers and therapeutic targets for HNSCC metastasis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Applebaum KM, Furniss CS, Zeka A, Posner MR, Smith JF, Bryan J et al. (2007). Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer. J Natl Cancer Inst 99: 1801–1810.
Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM et al. (2000). Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25–29.
Babuke T, Tikkanen R . (2007). Dissecting the molecular function of reggie/flotillin proteins. Eur J Cell Biol 86: 525–532.
Barker N, Clevers H . (2006). Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discovery 5: 997–1014.
Baudis M, Cleary ML . (2001). Progenetix.net: an online repository for molecular cytogenetic aberration data. Bioinformatics 17: 1228–1229.
Boyault S, Rickman DS, de Reynies A, Balabaud C, Rebouissou S, Jeannot E et al. (2007). Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 45: 42–52.
Braakhuis BJ, Senft A, de Bree R, de Vries J, Ylstra B, Cloos J et al. (2006). Expression profiling and prediction of distant metastases in head and neck squamous cell carcinoma. J Clin Pathol 59: 1254–1260.
Carles A, Millon R, Cromer A, Ganguli G, Lemaire F, Young J et al. (2006). Head and neck squamous cell carcinoma transcriptome analysis by comprehensive validated differential display. Oncogene 25: 1821–1831.
Chung CH, Parker JS, Karaca G, Wu J, Funkhouser WK, Moore D et al. (2004). Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 5: 489–500.
Cromer A, Carles A, Millon R, Ganguli G, Chalmel F, Lemaire F et al. (2004). Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis. Oncogene 23: 2484–2498.
Dawson S, Higashitsuji H, Wilkinson AJ, Fujita J, Mayer RJ . (2006). Gankyrin: a new oncoprotein and regulator of pRb and p53. Trends Cell Biol 16: 229–233.
Dupuy A, Simon RM . (2007). Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting. J Natl Cancer Inst 99: 147–157.
Esteller M . (2007). Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8: 286–298.
Foltz G, Ryu GY, Yoon JG, Nelson T, Fahey J, Frakes A et al. (2006). Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma. Cancer Res 66: 6665–6674.
Forastiere A, Koch W, Trotti A, Sidransky D . (2001). Head and neck cancer. N Engl J Med 345: 1890–1900.
Glas AM, Floore A, Delahaye LJ, Witteveen AT, Pover RC, Bakx N et al. (2006). Converting a breast cancer microarray signature into a high-throughput diagnostic test. BMC Genomics 7: 278.
Gollin SM . (2001). Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease. Head Neck 23: 238–253.
Gu LH, Coulombe PA . (2007). Keratin function in skin epithelia: a broadening palette with surprising shades. Curr Opin Cell Biol 19: 13–23.
Han C, Liu H, Liu J, Yin K, Xie Y, Shen X et al. (2005). Human Bex2 interacts with LMO2 and regulates the transcriptional activity of a novel DNA-binding complex. Nucleic Acids Res 33: 6555–6565.
Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado MP et al. (2007). Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst 99: 777–789.
Ioannidis JP . (2007). Is molecular profiling ready for use in clinical decision making? Oncologist 12: 301–311.
Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U et al. (2003). Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249–264.
Jarvinen AK, Autio R, Haapa-Paananen S, Wolf M, Saarela M, Grenman R et al. (2006). Identification of target genes in laryngeal squamous cell carcinoma by high-resolution copy number and gene expression microarray analyses. Oncogene 25: 6997–7008.
Kaklamani VG, Gradishar WJ . (2006). Gene expression in breast cancer. Curr Treat Options Oncol 7: 123–128.
Le Tourneau C, Velten M, Jung GM, Bronner G, Flesch H, Borel C . (2005). Prognostic indicators for survival in head and neck squamous cell carcinomas: analysis of a series of 621 cases. Head Neck 27: 801–808.
Ludwig JA, Weinstein JN . (2005). Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 5: 845–856.
Nguyen DX, Massague J . (2007). Genetic determinants of cancer metastasis. Nat Rev Genet 8: 341–352.
Ragin CC, Taioli E, Weissfeld JL, White JS, Rossie KM, Modugno F et al. (2006). 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours. Br J Cancer 95: 1432–1438.
Ramaswamy S, Ross KN, Lander ES, Golub TR . (2003). A molecular signature of metastasis in primary solid tumors. Nat Genet 33: 49–54.
Roepman P, Kemmeren P, Wessels LF, Slootweg PJ, Holstege FC . (2006). Multiple robust signatures for detecting lymph node metastasis in head and neck cancer. Cancer Res 66: 2361–2366.
Roepman P, Wessels LF, Kettelarij N, Kemmeren P, Miles AJ, Lijnzaad P et al. (2005). An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 37: 182–186.
Sanderson JT . (2006). The steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals. Toxicol Sci 94: 3–21.
Schlecht NF, Burk RD, Adrien L, Dunne A, Kawachi N, Sarta C et al. (2007). Gene expression profiles in HPV-infected head and neck cancer. J Pathol 213: 283–293.
Simonin F, Karcher P, Boeuf JJ, Matifas A, Kieffer BL . (2004). Identification of a novel family of G protein-coupled receptor associated sorting proteins. J Neurochem 89: 766–775.
Slebos RJ, Yi Y, Ely K, Carter J, Evjen A, Zhang X et al. (2006). Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res 12: 701–709.
Sobin LH, Fleming ID . (1997). TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 80: 1803–1804.
Song D, Liu G, Luu-The V, Zhao D, Wang L, Zhang H et al. (2006). Expression of aromatase and 17beta-hydroxysteroid dehydrogenase types 1, 7 and 12 in breast cancer. An immunocytochemical study. J Steroid Biochem Mol Biol 101: 136–144.
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102: 15545–15550.
van de Rijn M, Perou CM, Tibshirani R, Haas P, Kallioniemi O, Kononen J et al. (2002). Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol 161: 1991–1996.
Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A et al. (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034.
Vilar M, Murillo-Carretero M, Mira H, Magnusson K, Besset V, Ibanez CF . (2006). Bex1, a novel interactor of the p75 neurotrophin receptor, links neurotrophin signaling to the cell cycle. EMBO J 25: 1219–1230.
Zhou X, Temam S, Oh M, Pungpravat N, Huang BL, Mao L et al. (2006). Global expression-based classification of lymph node metastasis and extracapsular spread of oral tongue squamous cell carcinoma. Neoplasia 8: 925–932.
Acknowledgements
We are extremely thankful for the important contributions made by Jaqueline Godet (CIT project scientific manager), the CIT platforms (Affymetrix IGBMC: Philippe Kastner, Christelle Thibault, Doulaye Dembélé; BAC arrays IGBMC: Stan du Manoir, Christelle Arnold; QRT–PCR RNA analysis St Louis: Jessica Zucmann-Rossi), Christine Macabre (technical help), Fabien Petel (data submission to EBI), the IGBMC core facilities and Guy Bronner (providing tumour samples).
Financial support: Ligues Nationale et Régionales (Bas et Haut Rhin) contre le Cancer, CNRS, INSERM.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary information accompanies the paper on the Oncogene website (http://www.nature.com/onc)
Supplementary information
Rights and permissions
About this article
Cite this article
Rickman, D., Millon, R., De Reynies, A. et al. Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays. Oncogene 27, 6607–6622 (2008). https://doi.org/10.1038/onc.2008.251
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2008.251
Keywords
This article is cited by
-
Flotillin membrane domains in cancer
Cancer and Metastasis Reviews (2020)
-
Clinical, pathophysiologic, and genomic analysis of the outcomes of primary head and neck malignancy after pulmonary metastasectomy
Scientific Reports (2019)
-
Systematic analysis of genes involved in oral cancer metastasis to lymph nodes
Cellular & Molecular Biology Letters (2018)
-
Angiogenesis and evading immune destruction are the main related transcriptomic characteristics to the invasive process of oral tongue cancer
Scientific Reports (2018)
-
Gene expression and adaptive noncoding changes during human evolution
BMC Genomics (2017)